PSIP

Adverse Drug Events (ADE) due to product safety problems, and medication errors due to human factors (HF) are a major Public Health issue. They endanger the patients¿ safety and originate considerable extra hospital costs. Healthcare ICT applications should help reducing the prevalence of preventable ADE, by providing healthcare professionals and patients with relevant knowledge (guidelines, recommendations, etc.).

But their efficiency is impeded by two major drawbacks:

  • lack of reliable knowledge about ADE
  • poor ability of ICT solutions to deliver contextualised knowledge focused on the problem at hand, aggravated by a poor consideration of causative HF.

The objective of the project Patient Safety through Intelligent Procedures in Medication (PSIP) is (1) to facilitate the systematic production of epidemiological knowledge on ADE and (2) to ameliorate the entire medication cycle in a hospital environment.

The first sub-objective, SO, is to innovatively produce knowledge on ADE: to know, as exactly as possible, per hospital, their number, type, consequences and causes, including HF. Data Mining of the structured hospital data bases, and Semantic Mining of Data Collections of free-texts (letters, reports), will give a list of observed ADEs, with frequencies and probabilities, thus giving a better understanding of potential risks.

The second SO is to develop a set of innovative knowledge based on the mining results and to deliver a contextualised knowledge fitting the local risk parameters, in the form of alerts and decision support functions. This knowledge will be implemented in a PSIP-platform independently of existing ICT applications. These applications will connect to the platform to access and integrate the knowledge in their local system. The design and development cycle of the PSIP solution will be HF oriented.

Dissemination plans will be developed taking into account other uses (medical devices, primary and tertiary Healthcare).

For further information, please visit:
http://www.psip-project.eu

Project co-ordinator:
CENTRE HOSPITALIER REGIONAL ET UNIVERSITAIRE DE LILLE

Partners:

  • KITE SOLUTIONS S.N.C. DI DUNNE CATHERINE E C.
  • AALBORG UNIVERSITET
  • ORACLE FRANCE SAS
  • REGION HOVEDSTADEN
  • IBM DANMARK A/S
  • CENTRE HOSPITALIER DE DENAIN
  • VIDAL S.A.
  • IDEEA ADVERTISING SRL
  • EVALAB
  • MEDASYS SA
  • CENTRE HOSPITALIER UNIVERSITAIRE DE ROUEN
  • ARISTOTLE UNIVERSITY OF THESSALONIKI
  • UMIT - PRIVATE UNIVERSITAET FUER GESUNDHEITSWISSENSCHAFTEN, MEDIZINISCHE INFORMATIK UND TECHNIK GESELLSCHAFT MBH

Timetable: from 01/2008 – to 04/2011

Total cost: € 9.946.770

EC funding: € 7.268.981

Programme Acronym: FP7-ICT

Subprogramme Area: Advanced ICT for risk assessment and patient safety

Contract type: Collaborative project (generic)


Related news article:

Most Popular Now

Stanford Medicine Study Suggests Physici…

Artificial intelligence-powered chatbots are getting pretty good at diagnosing some diseases, even when they are complex. But how do chatbots do when guiding treatment and care after the diagnosis? For...

OmicsFootPrint: Mayo Clinic's AI To…

Mayo Clinic researchers have pioneered an artificial intelligence (AI) tool, called OmicsFootPrint, that helps convert vast amounts of complex biological data into two-dimensional circular images. The details of the tool...

Adults don't Trust Health Care to U…

A study finds that 65.8% of adults surveyed had low trust in their health care system to use artificial intelligence responsibly and 57.7% had low trust in their health care...

Testing AI with AI: Ensuring Effective A…

Using a pioneering artificial intelligence platform, Flinders University researchers have assessed whether a cardiac AI tool recently trialled in South Australian hospitals actually has the potential to assist doctors and...

AI Unlocks Genetic Clues to Personalize …

A groundbreaking study led by USC Assistant Professor of Computer Science Ruishan Liu has uncovered how specific genetic mutations influence cancer treatment outcomes - insights that could help doctors tailor...

The 10 Year Health Plan: What do We Need…

Opinion Article by Piyush Mahapatra, Consultant Orthopaedic Surgeon and Chief Innovation Officer at Open Medical. There is a new ten-year plan for the NHS. It will "focus efforts on preventing, as...

Deep Learning to Increase Accessibility…

Coronary artery disease is the leading cause of death globally. One of the most common tools used to diagnose and monitor heart disease, myocardial perfusion imaging (MPI) by single photon...

People's Trust in AI Systems to Mak…

Psychologists warn that AI's perceived lack of human experience and genuine understanding may limit its acceptance to make higher-stakes moral decisions. Artificial moral advisors (AMAs) are systems based on artificial...

Relationship Between Sleep and Nutrition…

Diet and sleep, which are essential for human survival, are interrelated. However, recently, various services and mobile applications have been introduced for the self-management of health, allowing users to record...

AI Model can Read ECGs to Identify Femal…

A new AI model can flag female patients who are at higher risk of heart disease based on an electrocardiogram (ECG). The researchers say the algorithm, designed specifically for female patients...

New AI Tool Mimics Radiologist Gaze to R…

Artificial intelligence (AI) can scan a chest X-ray and diagnose if an abnormality is fluid in the lungs, an enlarged heart or cancer. But being right is not enough, said...

DMEA 2025 - Innovations, Insights and Ne…

8 - 10 April 2025, Berlin, Germany. Less than 50 days to go before DMEA 2025 opens its doors: Europe's leading event for digital health will once again bring together experts...